A Phase 4 interventional study of biliary stent in Unresectable Hilar Cholangiocarcinoma, sponsored by Khon Kaen University. Status unknown at 1 site in Thailand. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2008-09-04.
Sponsored by Khon Kaen University · Phase 4, Interventional, and Supportive care
The purpose of this study is to compare the quality of life in patients with unresectable hilar cholangiocarcinoma on palliative metallic stent versus plastic Stent.
In the patient with unresectable hilar cholangiocarcinoma,palliative biliary stent is the one way to help him.
The aim of palliative treatment is to improve quality of life and relief symptom,or sometime ,extended survival rate.
There are two types of biliary stent:
The main drawback of plastic stent is relatively high occlusion rate, but its advantage is the lower cost.
In the reasons of higher occlusion rate , the lower cost of plastic stent versus metallic stent that should be stent exchange when occluded, so we would to know about quality of life in both group.
914 studies on the registry are indexed under Cholangiocarcinoma; 286 are open to participants now.
This study's planned enrollment of 80 is above the median of 50 across 687 interventional studies indexed under Cholangiocarcinoma.
Browse Cholangiocarcinoma studies →Khon Kaen University is the lead sponsor of 160 studies on the registry; 24 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
metallic stent group
Device: biliary stent
plastic stent group
Device: biliary stent
Metallic stent of plastic stent was inserted into right or left hepatic duct which was planed before intervention using CT scan or MRCP
Also known as: Self expandable metallic stent, Amsterdam type plastic stent
To assessment of the quality of life of patient with unresectable hilar cholangiocarcinoma after palliative biliary stent.
Time frame: 2-4 weeks
To assessment of early and late complication after palliative stent.
Time frame: After stent insertion for sixth month and one year or until patients were expired
Survival rate at sixth month and one year.
Time frame: After stent insertion for sixth month and one year or until patients were expired
This study is status unknown, as verified in Jul 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Khon Kaen University